Dr. Ajay Narayan Amarnani, MD

Dr. Amarnani practices at Dermatology & Skin Cancer Surgery Center in Mckinney, Texas.

Dr. Amarnani's NPI, 1376987123, was assigned on April 24, 2013. Dr. Amarnani graduated from Northeast Ohio Medical University in 2013. Dr. Amarnani holds Texas license S6349.

Dr. Amarnani's primary practice is Dermatology & Skin Cancer Surgery Center, at 1790 N Stonebridge Dr, Mckinney, TX 75071 in Collin County. The practice phone is (972) 390-9002.

Dr. Amarnani's primary practice is Dermatology & Skin Cancer Surgery Center in Mckinney, Texas. The medical group on file is Preferred Dermatology. Dmand AI also links Dr. Amarnani to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amarnani practices. Vendor and product names are available with a free account.

Dermatology is Dr. Amarnani's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Amarnani is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Amarnani's licenses on file in 7 states: Texas, Florida, North Carolina, New York, Virginia, Pennsylvania and Ohio.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses, itchy rashes and joint cyst among the conditions Dr. Amarnani treats.

CMS data shows 5,833 Medicare services from Dr. Amarnani across 31 procedure codes in 2024, for 857 Medicare patients. Medicare paid $856,330 for them. Every service was in an office.

CMS counts 857 Medicare patients who saw Dr. Amarnani in 2024. The largest group is 75 to 84, with 382 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Amarnani's median patient age at 75, with 42% women.

In 2024, Dr. Amarnani wrote 845 Medicare Part D claims for 437 patients. 98% of them were for generic drugs. CMS names the drug for 752 of them, across 14 drugs with 11 or more claims each, at $17,385 in total drug cost. In 2023, CMS named 839 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Amarnani for performance year 2024, reported as part of a group. Dr. Amarnani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 149 procedures of melanoma (skin cancer) excision by Dr. Amarnani, more than 96% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Amarnani in 2013. 2013 was the busiest year, with 2. Dr. Amarnani's most frequent co-authors are Robert T. Brodell, MD and Eliot Nathan Mostow, MD.

CMS Open Payments shows 28 general payments to Dr. Amarnani from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 86% of the total. Allergan Inc. paid the most, $599.

Dr. Amarnani graduated from Northeast Ohio Medical University in 2013.

Dr. Amarnani is in network with 23 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.